History of hepatitis C cirrhosis and HCC status post TACE RFA. ABDOMEN:LIVER, BILIARY TRACT: Cirrhotic liver morphology.RFA defect in the inferior segment VI measuring approximately 2.5 x 2.2 cm (series 10/265). There is new central nodular rim-enhancement (series 10/image 57) measuring up to 1.9 cm which washes out on delayed imaging suspicious for tumor recurrence.No significant change in the RFA defect in segment VIII measuring 4 x 2.1 cm demonstrating intrinsic heterogeneous T1 weighted signal (series 9, image 30)a compatible with proteinaceous or blood products. Surrounding postcontrast peripheral wedge-shaped progressive enhancement likely represents post-treatment fibrosis.No new arterial enhancing lesions.SPLEEN: No significant abnormality noted.PANCREAS: No significant abnormality noted.ADRENAL GLANDS: No significant abnormality noted.KIDNEYS, URETERS: Bilateral renal cysts and too small to characterize hyperintensities.RETROPERITONEUM, LYMPH NODES: No significant abnormality noted.BOWEL, MESENTERY: No significant abnormality noted.BONES, SOFT TISSUES: No significant abnormality noted.OTHER: No significant abnormality noted.
There is new nodular rim enhancement within the segment VI RFA ablation cavity measuring up to 1.9 cm which demonstrates washout and is suspicious for tumor recurrence.